Epilepsy & seizure disorders Board decisions

The Board has remanded the claims for service connection for various disabilities, including COPD, Crohn's disease, and seizure disorders. The VA is instructed to obtain all relevant treatment records from private healthcare providers and VA clinics.

The Board denied service connection for epilepsy, finding that there is no clear and unmistakable evidence of pre-service existence of the condition. The Board also found insufficient medical evidence to establish a link between the current epilepsy and military service or PTSD.

The Board has remanded the claims of service connection for seizure disorder and schizophrenia due to a lack of VA medical examinations. The Veteran was unable to be reached for the scheduled exams, and the Board finds good cause for not appearing.

The Veteran's claims for increased ratings, service connection, and benefits related to his disabilities are being remanded due to incomplete development.

The Veteran's seizures are rated at a 60 percent rating, effective from the date of the decision. The claims for increased ratings for TBI and radiculopathies remain pending and will be remanded to allow for further development.

The Board has remanded the claims for alcoholism and seizure disorder due to insufficient evidence. The pension benefits claim is also remanded for extraschedular consideration.

The Board denied service connection for the Veteran's claimed seizure disorder and acquired psychiatric disorder, finding no current disabilities associated with these conditions.

The Board has remanded the claims for service connection due to insufficient evidence regarding the Veteran's exposure at Fort McClellan and the nature of his claimed disabilities.

The Board has remanded the issues of service connection for TBI, bilateral hearing loss, cervical spine disability, petite mal seizures, and obstructive sleep apnea due to insufficient development or examination.

The Board has granted service connection for a brain tumor, finding that the evidence is at least in equipoise as to whether the Veteran's brain tumor manifested during his active duty service. Service connection was previously denied for seizures and TMJD on the basis of being sequelae of a brain tumor.

The Board has remanded the claims for service connection due to errors in the May 2021 decision, including insufficient discussion of a February 17, 2010 private opinion from Dr. J.B., and failure to address favorable buddy statements and SSA records.

The Board denied service connection for a seizure disorder, finding that the evidence does not support a link between the Veteran's current condition and his service-connected malaria.

The Board denied service connection for a back disorder, headache disorder, Hepatitis C, and seizure disorder due to lack of evidence linking these conditions to the Veteran's military service.

Service connection for residuals of right hand, middle finger injury is granted.,Service connection for bilateral hearing loss and seizures are denied.,Left shin splints and right shin splints cases are remanded.

The Board denied service connection for the claimed conditions, finding no direct link between the Veteran's active-duty service and his current disabilities.

The Board has granted service connection for the Veteran's epileptic seizures as secondary to his service-connected residuals of stroke associated with hypertension.

The Board has remanded the issues of service connection for residuals of traumatic brain injury, headaches, seizure disorder, and bilateral eye disorder due to duty-to-assist errors.

The Board has remanded the case for additional development due to a lack of VA examination on the nature and etiology of the Veteran's claimed epilepsy in relation to his service-connected arteriovenous malformation (AVM).

The Board has granted service connection for a seizure disorder, finding that the Veteran's current condition is at least as likely as not incurred during his military service.

The Board has granted restoration of the rating from 80% to 100%, effective August 1, 2020, for epilepsy and epileptic syndromes with complex partial seizures, residuals of brain tumor. Additionally, SMC at the S-1 rate is also restored effective August 1, 2020.